Facebook Linkedin Twitter
Inside Precision Medicine YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Hematologic and lymphatic cancer

Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
Oncology

YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Alice McCarthy
0
Tom and Emily whitehead
Multimedia

Not All Precision Medicine Heroes Wear Lab Coats

Jonathan D. Grinstein, PhD
0
Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
News & Features

Mantle Cell Lymphoma Patients May Not Need Stem Cell Transplant

0
Human bone marrow under the microscope to illustrate myelofibrosis blood cancer, the diagnosis of which could be aided by new AI tools
News & Features

High-Fiber Diets May Reduce Risk of GVHD after Bone Marrow, Stem Cell Transplants

0
Chronic myeloid leukemia cells or CML
News & Features

Terns Pharmaceuticals’ Allosteric Inhibitor Shows “Best-in-Class” Potential in Phase I CML Study

Chris Anderson
0
Hodgkin lymphoma, light micrograph
News & Features

Lab-Grown Human Immune System Can Check Cancer Patients’ Immune Responses

0
Acute myeloid leukemia (AML)
Molecular Dx

NIH Launches myeloMATCH Precision Medicine Trials for Myeloid Cancers

0
Lymphocytes and biomedical concept, 3d rendering.
News & Features

First Patient Dosed with In Vivo Gene Therapy for CAR T

Jonathan D. Grinstein, PhD
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

On/Off Switch for CAR-T Cell Therapy Shows Early Promise

0
Lymphoma cancer cell that can be targeted by CAR T-cell therapy
News & Features

Immunotherapy Plus Chemotherapy: A New Standard of Care for First-Line, Advanced Hodgkin Lymphoma

Alice McCarthy
0
123...27Page 1 of 27

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine